Form 4: PAVmed Director Granted 150,000 Restricted Shares

PAVmed Inc. Director Sundeep Agrawal received a grant of 150,000 restricted common stock shares, vesting in May 2028.

Summary

• Sundeep Agrawal, a Director of PAVmed Inc. (PAVM), was granted 150,000 shares of common stock.
• The transaction date for this grant was September 30, 2025.
• These shares are restricted stock granted under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan.
• The restricted stock has a single vesting date of May 20, 2028.
• The shares are subject to forfeiture if the requisite service period is not completed.
• Following this transaction, Sundeep Agrawal beneficially owns 162,195 shares of common stock.

Sentiment

Score: 6

Explanation: The filing reports a standard equity grant to a director, which is generally viewed as a neutral to slightly positive event as it aligns insider interests with shareholders. No negative operational or financial news is present.

Positives

• The grant of restricted stock aligns the interests of Director Sundeep Agrawal with those of shareholders, incentivizing long-term performance.
• The transaction is part of an existing, approved equity plan (Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan), indicating structured compensation.

Negatives

• No direct negative financial or operational impacts are reported in this Form 4 filing.

Risks

• The granted restricted stock is subject to forfeiture if the requisite service period is not completed by the vesting date of May 20, 2028.

Future Outlook

The grant of restricted stock with a vesting date of May 20, 2028, indicates an expectation of continued service from Director Sundeep Agrawal to the company.

Industry Context

Equity grants, particularly restricted stock, are a common form of compensation for directors and executives in publicly traded companies across various industries, including healthcare and medical technology, to align their interests with long-term shareholder value.

Comparison to Industry Standards

• The use of restricted stock grants as a component of director compensation is a standard practice in the U.S. public company landscape, comparable to compensation structures at peer companies in the medical technology sector.
• The vesting schedule, tied to continued service, is typical for such equity awards, aiming to retain key personnel and incentivize long-term commitment.

Corporate Governance

Related Party Transactions

• The grant of 150,000 shares of restricted common stock to Director Sundeep Agrawal constitutes a related party transaction, which is a standard form of director compensation under the company's approved equity plan.

Stakeholder Impact

• Shareholders: Potential for minor dilution from the issuance of new shares, but also increased alignment of a director's interests with long-term shareholder value.
• Employees: No direct impact on general employees mentioned.

Next Steps

• Sundeep Agrawal must complete the requisite service period for the restricted stock to vest on May 20, 2028.

Key Dates

Keywords

PAVmed, PAVM, Sundeep Agrawal, Form 4, Restricted Stock, Equity Grant, Director Compensation, Insider Transaction, Long-Term Incentive Plan